SK

Subodh Kumar Sinha

Active Director Director DIN 09561484
DIN 09561484 First appointment Apr 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Subodh Kumar Sinha

Data last updated:

Subodh Kumar Sinha is a Director at Scafell Pharmaceuticals Private Limited (since 2022). The company operates in Healthcare. Scafell Pharmaceuticals Private Limited reported revenue of ₹55,745 (FY 2022).

DIN 09561484
Primary Designation Director
Industry Healthcare
First Appointment 06 Apr 2022
Oldest Company Age 7 yrs
Largest company Scafell Pharmaceuticals Private Limited · ₹55,745 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Apr 20222019₹55,745 (FY 2022)Active

Board colleagues of Subodh Kumar Sinha

Directorship timeline

Open interactive timeline →
Scafell Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Subodh Kumar Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subodh Kumar Sinha

Subodh Kumar Sinha currently holds 1 directorship: Scafell Pharmaceuticals Private Limited (Director, since 06 Apr 2022, revenue ₹55,745 (FY 2022)).

Subodh Kumar Sinha was first appointed on 06 Apr 2022 as Director at Scafell Pharmaceuticals Private Limited.

The current boards of Subodh Kumar Sinha's companies include Rajesh Kumar Singh (Scafell Pharmaceuticals Private Limited), Ratnesh Kumar (Scafell Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available